HLA-C and neoplasm: Whole-exome sequencing (WES) and RNA-seq data based on next-generation sequencing (NGS) enable highly sensitive identification of tumor mutated genes, while MS directly detects MHC-present peptides, verifying the expression of mutant mRNA and peptides at the protein level.